Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Total stock-based compensation (SBC) expense by Quarter
Total stock-based compensation (SBC) expense ($M) ($M)
Gilead Sciences Total stock-based compensation (SBC) expense: $231M in Q2 2026, up 2.7% from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-08-06) ↗
Reported in Form 10-Q / 10-K Note 13 Stock-Based Compensation.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total stock-based compensation (SBC) expense
- SBC expense — Cost of goods sold ($M)–
- SBC expense — Research and development ($M)–
- SBC expense — Selling, general and administrative ($M)–
- SBC income tax benefit ($M)–
- SBC expense, net of tax ($M)–
- SBC expense by award type — Restricted Stock Units (RSUs, $M)–
- SBC expense by award type — Performance Share Units (PSUs, $M)–
- SBC expense by award type — Stock Options ($M)–
- SBC expense by award type — Employee Stock Purchase Plan (ESPP, $M)–
- RSU rollforward — Nonvested shares at period-end (M shares)–
- PSU rollforward — Nonvested shares at period-end (M shares)–
Cite this data
StockData. (2026). Gilead Sciences Total stock-based compensation (SBC) expense ($M), quarterly Q1 2014–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/sbc-tot
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.